NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2042240074

Registered date:20/08/2024

A validation study of the voice-based cognitive assessment program

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedHealthy adults, Suspected cognitive decline.Picking up undiagnosed or untreated patients at fam
Date of first enrollment20/08/2024
Target sample size99
Countries of recruitment
Study typeInterventional
Intervention(s)Using this device, cognitive function tests and psychological tests (MoCA-j, CDR, MMSE-J) will be conducted by recording spoken voice, and the test results will be compared.

Outcome(s)

Primary OutcomeTo evaluate the MoCA-J score, sensitivity and specificity of this device for definitive diagnosis results
Secondary OutcomeThe correlation between the test results of this device and the CDR Global Score and MMSE-J score will be evaluated.

Key inclusion & exclusion criteria

Age minimum>= 50age old
Age maximum< 90age old
GenderBoth
Include criteria1. Subjects aged 50 to 90 years old who meet the following criteria (1), (2), or (3). (1)Dementia (already diagnosed) (2) Suspected cognitive decline (3) Healthy adults 2.Able to take a medical interview (conversation with a doctor or medical professional). 3. Able to be accompanied by a co-participant (study partner) who can answer the CDR. 4.Who can obtain written consent from the person or his / her substitute or study partner.
Exclude criteria1.Those who have been judged by a doctor to have difficulty speaking normally. 2. Who has been diagnosis with a psychiatric disorder such as depression. 3. Meets any of the following criteria (1), (2), or (3). (1)Dementia (diagnosed) Who has undergone neuropsychological examination within last 3 months. (2)Suspected cognitive decline Who has undergone neuropsychological examination within last 6 months. (3)Healthy adult Who has undergone neuropsychological examination within last 6 months. 4.Who has been judged by a doctor that suspected to have a sevier respiratory disease. 5.Who has confirmed participate of development of this AI system. 6.Who has been judged by a doctor not to be suitable for this study by any reasons.

Related Information

Contact

Public contact
Name Clinical trial contact
Address 338 Kokusai Building, 1-1 Marunouchi 3-chome, Chiyoda-ku tokyo Tokyo Japan 100-0005
Telephone +81-3-6810-2130
E-mail clinical_study@dm-partners.jp
Affiliation Dream Medical Partners Co., Ltd.
Scientific contact
Name kimimasa Tobita
Address 338 Kokusai Building, 1-1 Marunouchi 3-chome, Chiyoda-ku tokyo Tokyo Japan 100-0005
Telephone +81-3-6810-2130
E-mail clinical_study@dm-partners.jp
Affiliation Dream Medical Partners Co., Ltd.